Media Library

Process operators in a clean room. Manufacturing facility for innovative cell and gene therapies in Stein, Switzerland.

Manufacturing facility for innovative cell and gene therapies in Stein, Switzerland.

A process operator with culture medium bag. Manufacturing facility for innovative cell and gene therapies in Stein, Switzerland.

Manufacturing facility for innovative cell and gene therapies in Stein, Switzerland.

Board member since 2020 | Vice-Chair since 2022

Board member since 2020

President, Global Health & Sustainability

Novartis has created a sophisticated process for manufacturing CAR T Cell Therapies. Novartis CAR-T Cell theapy is developed using the patient's own T-Cells which are part of the body immune system and play a central role in fighting disease.

An animated overview of the science behind CAR-T cell therapy.

Chronic myeloid leukemia, or CML, is a cancer of the blood and bone marrow in which the body overproduces white blood cells. 

Our goal is to change the practice of medicine for patients around the world, including previously undeserved populations in developing regions.

Acute lymphoblastic leukemia (ALL) is a cancer of the blood and lymphocytes, and is a common cancer diagnosis in children.